The Kennel Club is hosting its second Puppy Awareness Week to help improve the health and lives of dogs around the UK, and is seeking assistance from the veterinary profession.
Puppy Awareness Week is taking place from 8th - 14th September and aims to help people find a healthy, happy puppy that is right for their lifestyle, whilst raising awareness about the plight of puppies and breeding bitches born into cruel puppy farms.
To help, veterinary surgeons and nurses are being asked to join in the week, putting up posters and literature in client waiting areas, and selling Puppy Awareness Week badges for £2, which will go to the Kennel Club Charitable Trust.
Caroline Kisko, Kennel Club Secretary said: "It is vitally important that we spread the word about buying puppies responsibly. At veterinary surgeries there is a captive audience of animal lovers and we can't think of anyone better to communicate with. Not only are a vet's clients animal lovers and as such, potential new dog owners, but they may also make great champions of the cause, spreading the message about buying a puppy responsibly further afield.
"Sadly, we are seeing tens of thousands of puppies born each year suffer as puppy farms churn out litter after litter of undernourished and badly cared for puppies, and then selling them on to unsuspecting owners through pet shops, newspaper ads, online adverts and various other means. With help from veterinary practices we want to provide information throughout Puppy Awareness Week to help people understand how to buy a healthy, happy puppy, and to raise money for the Kennel Club Charitable Trust, which supports charities and organisations that are making dogs' lives better."
To get involved in Puppy Awareness Week and receive literature and Puppy Awareness badges, contact the Kennel Club press office at press.office@thekennelclub.org.uk.
Puppy Awareness Week will kick off at Pup Aid on September 8th in Primrose Hill, London and will run until 14th September. To find out more, visit www.thekennelclub.org.uk/paw.
Norbrook Laboratories Ltd has announced the launch of Pestigon, a fipronil spot-on solution for cats and dogs.
Rebekah Dudek, Norbrook Veterinary Advisor said: "Pestigon offers a fast-acting and long-lasting treatment for cats and dogs suffering from flea and tick irritations. The new product will have an immediate effect against flea infestations and will kill ticks within the first 24 - 48 hours of application. Fipronil is a tried and tested ingredient with proven efficacy against fleas and ticks. Pestigon provides a fast-acting treatment whose effectiveness will continue against new infestations of fleas for up to 58 days on dogs and 37 days in cats and against ticks for up to 30 days in dogs and 21 days in cats."
To coincide with the launch of Pestigon, Norbrook has rebranded its Permaguard household spray which is now available with 12 month protection.
Rebekah said: "The total life cycle of a flea can last from a couple of weeks to several months. Only adult fleas live on cats or dogs while the eggs, larvae and pupae can be found around the house in carpet, furniture, bedding etc for up to a year or more. It is therefore crucial that pet owners treat the household to break the life cycle and ensure effective and lasting flea control. Pestigon and Permaguard together will give pet owners a complete treatment."
Pestigon range offers 5 alternatives for cats and dogs depending on size and comes with colour co-ordinated pipettes available in packs of 3, 6 and 24 to allow for single or multiple pipette dispensing.
Norbrook's Small Animal Brand Manager, Michelle Jones said: "Pestigon is licensed as a POM-V product and will be sold exclusively through veterinary practices. We have produced a range of marketing materials for veterinary practices to help them offer support on flea and tick control in the home to their customers."
Orders for Pestigon and Permaguard can be placed through your Norbrook representative now.
Boehringer Ingelheim Vetmedica has launched a new Canikur Pro website - www.canikurpro.co.uk - to provide pet owners with advice on digestive upset and offer a quick reference guide to using Canikur Pro.
The site offers information about the common causes of digestive upset, including dietary indiscretions, stress due to a change in circumstances and underlying gut problems.
The site also contains information about how Canikur Pro works, how to give the product and where to buy it, plus tips for supporting the recovery of a dog's gut health such as providing a constant supply of fresh water, offering a bland diet and providing access to outside areas to reduce accidents.
In addition, the site contains a 'veterinary only' area where veterinary professionals can download client materials.
The Webinar Vet has released the results of a survey which shows that its members are far exceeding their 35 hour CPD target.
Launched just over two years ago, The Webinar Vet was the first company in the UK to specialise in web-based CPD for vets and now has nearly 1000 members from around the globe.
The Webinar Vet founder Anthony Chadwick MRCVS said: "Our members average over 60 hours of online CPD per year. Indeed several members are exceeding 100 hours a year including workshops, and some have even recorded over 200 hours of total CPD!
"There will always be a need for workshop CPD, but most vets and VNs can get the majority of the updates and information they need online. However we believe that in many cases it's not a simple swap - the convenience of online CPD means that many vets and VNs are earning more total hours, which can only be a good thing for the profession.
"Many vets and VNs are juggling busy family lives with work in practice, and the convenience of viewing and participating in webinars from your own home or in a practice lunch break is both cost and time saving, not to mention the reduction in carbon footprint."
Virbac Animal Health is calling on practices to prepare for Canine Prostate Awareness Month (CPAM), being held by the company in November to highlight the prevalence of the disease and to encourage owners and practices to test for it.
Last year, 400 practices sign up to support the event, and the company says that feedback from many taking part confirmed a significant lack of understanding among clients as to the risk of prostate disease in dogs.
Canine Prostate Awareness Month is timed to coincide with 'Movember', when thousands of men grow moustaches to raise funds for male prostate and testicular cancer. During the month, Virbac is providing promotional materials including dog leads; educational and display materials and a press release for local media.
Chris Geddes MRCVS, Virbac Product Manager, said: "With more than 80% of entire male dogs over the age of five suffering from Benign Prostatic Hyperplasia (BPH)¹, we wanted to give practices a reason to highlight the risk and encourage owners to test for it. Timing CPAM to coincide with Movember seemed a good way to interest dog owners at a time when some might be considering the state of their own prostate.
"The support we received last year confirmed that it was a topic which practices were keen to discuss with dog owners so we're already planning to make the initiative even bigger and better this year."
Stephen Bamber, Principal at participating practice Warwickshire-based Avonvale Vets, added: "CPAM was an attractive campaign as it was a bit different. It offered the opportunity to see some of our older patients with other, less obvious pathologies. Non-symptomatic testicular tumours in particular surfaced in the checks we did. Clients generally had little idea about dogs' prostates so it gave us a good platform to discuss prostate disease with them."
Virbac has introduced OdelisTM CPSE, the first ELISA test to screen for, diagnose and monitor BPH, available from three UK diagnostic laboratories. The company says it's a cost-effective, precise and reliable alternative to rectal palpation. Virbac also offers Ypozane, a tablet treatment for BPH which takes effect within a week and lasts for up to six months.
Chris added: "BPH is an unpleasant condition occurring in nearly all entire dogs as they get older, but one which is entirely treatable. We hope that, by running our Prostate Awareness Campaign at a time when the media spotlight is already on the dangers of prostate cancer in men, we can help spread the message that owners should be monitoring older dogs for signs of prostate disease."
For further information on the Prostate Awareness Campaign, email cpam@virbac.co.uk; contact your Virbac Territory Manager or contact the company direct on 01359 243243.
References
Dechra Veterinary Products has published a range of case studies to support its new campaign focused on the diagnosis and treatment of otitis externa.
The studies have been written by Referral Dermatologist Sue Paterson MA, VetMB, DVD, DipECVD, MRCVS, RCVS European Specialist in Veterinary Dermatology and Peter Forsythe BVM&S, DVD, MRCVS, RVCS Specialist in Veterinary Dermatology.
Developed as part of the Time to Change campaign, the real-life examples feature a series of problems and solutions associated with otitis, supported by clear images and photomicrographs.
Larry King, Senior Brand Manager, Dechra Veterinary Products, said: "We have created a range of in-depth case study materials for use by vets and vet nurses which will support identification and management of otitis externa, one of the more frequent conditions seen in general practice.
"As veterinary professionals are aware, otitis is common and can be challenging to diagnose and treat. These studies address individual cases and demonstrate how the Dechra dermatology range can be used effectively.
"Topics covered in the case studies include the types of otitis presented by each animal, how individual organisms were identified using cytology and how long treatment was continued."
The case studies, which feature Malassezia, staphylococcal and Proteus infections, also discuss the underlying causes and steps taken after treatment with Canaural and various ear cleaners.
The Time to Change campaign has been launched to support a best practice approach to otitis which includes the identification of the organisms causing infection through cytology, support the selection of the correct treatment and assist with educating clients on how to apply and use products correctly.
For further information visit www.dechra.com/timetochange. The website also highlights the benefits of Dechra Veterinary Products' range of topical treatments and ear flushes, including Canaural, CleanAural, CerumAurual, TrizAural and MalAceticAural.
Petplan has launched a new service to pay vet claims direct to practice bank accounts via BACS.
Petplan says it pays out nearly £3 million in claims each week, which is the equivalent of paying £35,000 per year to each veterinary practice in the UK. Paying practices by BACS means that the money is received faster and there is no administration required by the practice, freeing up more time for clinical work.
As part of this new service, practices also receive a detailed statement by email providing a breakdown of the client claims the payment relates to.
To register to receive claim payments by BACS, visit petplanvet.co.uk and complete an online form.
Simon Masding, Petplan's Head of Sales and Partnerships said: "Petplan has a great relationship with vet surgeries and we know in the last few years some practices have had increasing pressure on cash flow due to reduced footfall and rising costs. We are constantly looking for new, smarter ways of working to help our partners and wanted to get claim payments to vets even faster."
Petplan's Vet of the Year Brian Faulkner said: "Most people become vets because they love to work with animals, and the paperwork is merely a downside of the job. It's great to see that Petplan has reduced the time we have to dedicate to admin, meaning we can concentrate on the important things, like improving the health of Britain's pets."
For more information visit www.petplanvet.co.uk
A team of top equine vets is aiming to raise £125,000 for the Society for the Protection of Animals Abroad (SPANA) by travelling 3000 miles through Europe by motorbike between 22nd August and 9th September.
Sponsored by Elanco Animal Health, the seven-strong team is planning to travel through Belgium, the Netherlands, Germany, Switzerland, France, Italy, Morocco and Spain and deliver lectures to eight European and African veterinary schools in just two weeks.
Led by Professor Derek Knottenbelt from the University of Liverpool, the team also includes Professor Josh Slater from Royal Veterinary College, Dr John Burford from the University of Nottingham, Dr Caroline Hahn from the University of Edinburgh, Dr Michael Hewetson from the University of Helsinki, Ms Joanne Suthers from the University of Liverpool and Dr Edmund Hainisch from the University of Vienna. They are being supported by Jeremy Hulme, chief executive of SPANA, Nic Van Gelder, fundraising and supporter care administrator at SPANA and Cerian Stephens.
All money raised will provide SPANA with diagnostic and surgical equipment for the charity's veterinary clinics for working animals in Mali and Mauritania and for the further development of the Bamako Disabled Riding Centre in Mali.
Mike Brown, Elanco's UK and Ireland country director said: "We are delighted to be sponsoring the Vets with Horsepower European Tour which will raise vital funds for working animals in some of the world's poorest countries. This is just one of the many worthwhile initiatives we are supporting in 2012 which focus on alleviating world hunger, spearheading agricultural leadership, enhancing the human-animal bond and caring for the environment."
For further information on the Vets with Horsepower European Tour visit www.spana.org/horsepower.
The Badger Trust's legal challenge to Defra's plans for targeted badger cull pilots has failed in the High Court on all three grounds.
Whilst the RSPCA has expressed its disappointment, the British Veterinary Association and British Cattle Veterinary Association have welcomed the judgement.
BVA President Carl Padgett said: "We are pleased that the High Court has ruled Defra's policy lawful and that the pilot badger culls can now go ahead.
"The BVA and BCVA believe that the government's approach has been robust and justifiable as it is based on our current scientific knowledge.
"Bovine TB is a devastating disease and we must tackle the disease in wildlife alongside cattle controls if we are to get on top of it."
David Bowles, the RSPCA's Director of Communications, said: "We are bitterly disappointed that the UK Government in England is ploughing on with plans to kill badgers but the fight is not over yet.
"We believe culling is not a long-term, sustainable solution and will be of little help in reducing the disease - perhaps even making things worse in some areas. It will wipe out huge numbers of this much-loved species, virtually eliminating badgers from these areas, including many animals which are healthy.
"It is not as if there aren't alternatives to a cull. Vaccination could be a more effective and sustainable way of dealing with the disease, and one which does not involve killing most of the badger population in very large areas of the countryside."
Virbac Animal Health has launched Speed Leish K, a diagnostic test for canine leishmaniosis.
Speed Leish K detects antibodies directed against the kinesins of leishmania using a Kinesin Capture Complex (KCC), a complex of recombinant proteins with strong immunogenic power at all stages of infection. Virbac says that in trials the test has demonstrated 98.5% overall accuracy.*
Virbac Product Manager Simon Boulton MRCVS said: "Leishmaniosis presents a growing threat to UK dogs, particularly those which travel with their owners on holiday to regions where the disease is endemic.
"Speed Leish K should be used as part of the primary CaniLeish vaccination protocol in animals previously at risk of exposure to ensure only health animals are vaccinated. The test can also be used to screen for the disease in animals suspected to be infected."
Speed Leish K is presented in kits of two or six tests and can be stored for 24 months at room temperature.
The anti-emetic, Cerenia (maropitant citrate), has gained licenses for use in puppies from as young as eight weeks of age and in cats from 16 weeks of age in the prevention and treatment of vomiting and reduction of nausea.
Cerenia is an NK-1 receptor antagonist which Pfizer says is effective against both peripheral and central emetic stimuli by acting on the final common pathway for emesis. It is, according to the company, the only NK-1 receptor antagonist licensed for dogs and cats.
Pfizer adds that in addition to the use for general emesis in puppies, Cerenia can also be used for chemotherapy-induced nausea in dogs. Studies in human oncology show that some patients receiving chemotherapy consider nausea to be more distressing than vomiting1. and the use of NK-1 receptor antagonists has shown clear benefits in the prevention of nausea and vomiting in chemotherapy-treated humans2. Cerenia tablets are also for the treatment for motion sickness in dogs aged 16 weeks or older, delivering claimed efficacy up to 93% without sedating the dog.
Kate Grocott, Product Manager for Cerenia, said: "Already successfully used in the treatment and prevention of vomiting and chemotherapy nausea in dogs, the new licence is a positive step forward for the prevention and early treatment of vomiting for puppies as young as eight weeks of age and cats from 16 weeks old. Being able to deploy Cerenia in these cases, will improve quality of life, and increases the likelihood of the animal voluntarily taking food and water thereby assisting in the recovery where there is underlying disease."
The new licence for treatment of cats with Cerenia is associated with the injectable form, while puppies may be treated with either an injection or tablets.
For further information, contact your Pfizer Animal Health account manager or call 0845 300 8034.
Vetoquinol has launched a pain monitoring system along similar lines to those used in humans, which can be used by vets and owners to measure pain over time and assess different treatment strategies in dogs.
According to the company, it is widely accepted that all mammals experience pain1and that under treatment is a big issue. Guidelines in treating human pain issued by NICE state that: 'evidence suggests that pain caused by advanced disease remains under-treated'. Veterinary medicine faces a harder task in recognising and treating pain effectively as it relies on behaviour rather than verbal communication.
In human medicine, Client Specific Outcome Measures have been used to assess treatment strategies focussing on identifying the degree of difficulty performing daily tasks on an individual patient to patient basis. Vetoquinol says its pain monitoring system is based on similar principles.
Robert Simpson, Product Manager for Cimalgex said: "The objective assessment of clinical outcomes are a continuing challenge in veterinary medicine; this is particularly true in chronic painful conditions such as osteoarthritis. Use of our Client Specific Outcome Measures form will allow vets and pet owners to more efficiently assess treatment to ensure that the patient is receiving appropriate analgesia.
The form can be adapted to give bespoke outcome measures which are agreed in consultation with the owners. This activity will increase interaction with pet owners and could increase loyalty to the practice; it could also be really useful in geriatric clinics etc as a method of assessing pain outside of consultations in practices."
To find out more or to request a monitoring pad for your practice, contact your Vetoquinol Territory Manager or call 01280 825424.
MSD Animal Health has launched a new Chronogest CR pack for practices starting a dialogue with sheep producer clients about planned breeding for 2013 lamb sales, and is offering a free applicator with every four packs purchased.
The Chronogest CR intra-vaginal sponges, impregnated with 20mg of cronolone (flugestone acetate) synthetic hormone, are now available in foil wrapped packs of 25. The packs protect the sponges from light and moisture.
MSD is reminding practitioners that sponging programmes must be planned at least six weeks in advance of mating, with PMSG-Intervet injections essential at sponge removal.
The new packs of 25 will be available when existing 25, 50 and 100 pack sizes sell out.
Further information on planned breeding - including newsletter copy and sheep producer advisory materials - is available from the MSD Animal Health veterinary support group (VSG) on 01908 685685 or via emailing vet-support.uk@merck.com
The BVA has welcomed an update report on dog breeding issues by the Associate Parliamentary Group for Animal Welfare (APGAW).
Working with a small group of stakeholders including the British Veterinary Association, Dogs Trust, Kennel Club and RSPCA, this report looks at what has been done since the first APGAW report in late 2009 and the airing of Pedigree Dogs Exposed (2008) and Pedigree Dogs Exposed: Three Years On (2012).
BVA Past President Harvey Locke said: "The BVA fully endorses the recommendations and practical solutions offered by this timely report."
Mr Locke drew attention to a number of points in the report's action plan including:
Mr Locke added: "I am pleased that the APGAW report recognises the vital role that education plays in tackling irresponsible dog ownership and would very much like to see the inclusion of animal welfare as part of the core curriculum.
"I am also delighted that the group recognises the value of a puppy contract. The BVA Animal Welfare Foundation and RSPCA have recently launched a puppy contract and puppy information pack (PIP) which arms buyers with the knowledge to give themselves the best chance of getting a fit, healthy and happy, well socialised pet to join their household. The contract and PIP have also been designed to help good breeders demonstrate the care and attention they have devoted to their puppies' breeding and upbringing.
"Much work has already been undertaken to improve dog breeding but there is much more to be done and the momentum must not be lost. I am most grateful to Neil Parish MP, chairman of APGAW, for his commitment to producing this report. It is an excellent means of keeping the issue high on the agenda by encouraging wider dialogue and debate within Parliament and in the EU."
The Kennel Club Charitable Trust has announced that nominations are now open for its new Veterinary Awards for veterinary surgeons, scientists and veterinary students that are carrying out innovative research that will help to improve dog health.
According to the charity, the Awards will identify and encourage visionary thinking, ambition and life-changing accomplishments and those who receive the awards will be passionate about making a difference for dogs. Each award provides a large funding programme to the recipient, which rewards them for their dedication and innovation in the field of canine health and welfare and invests in helping them to continue making a difference for dogs. The awards will be:
The awards will be judged by representatives from the veterinary profession and the world of scientific research, including experts in the nominees' selected fields. Dr. Alan Kelley, Dean Emeritus of The University of Pennsylvania School of Veterinary Medicine, will chair the distinguished committee selecting the International Prize Winner.
Vernon Hill, Founder and President of Metro Bank and Shirley Hill, whose Foundation underwrites the Awards, said: "Metro Bank is a visionary, innovative bank, and we support the same spirit in these prestigious awards. Dogs Rule at Metro Bank, and we welcome them in with fresh water bowls, treats and Metro Scarves 361 days a year. We look forward to our gift making a difference and supporting the future leaders in veterinary science."
Rosemary Smart, Kennel Club Chief Executive, said: "We are extremely pleased to be working with Vernon and Shirley in this exciting Awards scheme, which will reward and support those people whose work is making a difference to dogs' lives."
To nominate somebody for these awards contact: cas.oakes@thekennelclub.org.uk or write to:
Cas OakesThe Kennel Club Charitable Trust1-5 Clarges StreetPiccadillyLondonW1J 8AB
Nominations for the Student Inspiration should come from the Deans/Faculty Directors of British Veterinary Schools.
For further information and to find out how to enter visit: www.thekennelclub.org.uk/charitabletrust
Virbac Animal Health has launched an extra small version of its VeggieDent dental chews for dogs weighing less than 5kg.
Research commissioned by the company shows that 9% of all dogs in the UK weigh less than 5kg1 and that periodontal disease is over-represented in this group2.
According to the Kennel Club, celebrity culture is boosting the popularity of small breeds. Apparently there was a 25% increase in Kennel Club registrations of Chihuahuas in 2011, following publicity about Paris Hilton and her Chihuahua. Virbac says numbers of other small miniature breeds such as pugs are also growing rapidly.
Virbac says VeggieDent chews are designed to work with the animal's chewing action, 100% vegetable, highly palatable and feature a special design to increase chewing time. A recent study3 showed that a daily XS VeggieDent reduced halitosis as well as significantly reducing gingivitis, plaque, and tartar accumulation.
Chris Geddes MRCVS, Product Manager at Virbac said: "With growing numbers of very small dogs in the UK, we wanted to produce a chew which was exactly the right size for them.
VeggieDent Chews are already popular among dog owners because they are a nutritious and palatable plaque control aid, minimising tartar build up and improving breath odour. With the launch of the extra small size, we now offer the perfect chew for every size of dog."
For further information, contact your Territory Manager or call Head Office on 01359 243243.
References:
Virbac Animal Health has announced that its medical castration implant Suprelorin 9.4mg has received a marketing authorisation for use in ferrets.
The neutering of male ferrets (hobs) is recommended to suppress fertility, decrease odour and reduce territorial aggressive behaviour and urinary marking¹. According to Virbac, Suprelorin offers temporary sterilisation but without the need for surgery, and its use prevents the high Luteinizing hormone (LH)/Follicle-stimulating hormone (FSH) levels which occur following surgery and which can play a role in the development of hyperadrenocorticism².
Suprelorin is a slow-release implant containing the gonadotropin-releasing hormone (GnRH) agonist deslorelin. Once injected under the skin of healthy, sexually mature and entire ferrets, the continuous low release of deslorelin from the implant causes an interruption of the HPA circuit, leading to a reduction in LH/ FSH levels and therefore testosterone production. This results in a reduction of libido, spermatogenesis and testicle size.
The implant lasts for up to four years, at which stage the ferret can be re-implanted to maintain the effect.
Chris Geddes MRCVS, Virbac Product Manager, said: "For owners looking for a surgery-free route to the castration of male ferrets and the problems it can cause, Suprelorin provides a simple and effective alternative."
Suprelorin 4.7mg has been available for use in dogs since 2008. Suprelorin 9.4mg was launched in 2011.
For further information, please contact your Territory Manager or call Head Office on 01359 243243.
Ceva Animal Health has launched a new travel size 20ml bottle of Feliway Spray to help cat owners keep their pet comfortable whilst travelling this summer.
To promote the launch Ceva is giving away thousands of prizes to Feliway customers, offering them the chance to win a top prize of a spa day at Champneys, cat carriers, soft toys and travel stickers, whilst stocks last. To take part, customers need to enter their unique pack code via the Feliway Facebook page to toss an online coin to see what they have won.
In addition, veterinary surgeries that purchase a 12 pack of the 20ml spray will get a second 12 pack free.
Julia Wood, product manager at Ceva said: "Transporting cats even short distances, for necessary trips to the vet, cattery or to a local show, can easily become a nightmare for both the cat and the owner. We've introduced the new travel size spray to make it even more convenient for cat owners when they are on the move and we hope the extra competition incentive will drive sales for veterinary clinics."
BCF Technology has launched the Mindray DP-50 veterinary ultrasound system, a black and white entry level system that can be used in both the small animal and equine general practice.
According to the company, the DP-50 offers excellent black and white abdominal and cardiac images and the menu system for performing measurements, calculations and image review is very intuitive. The system allows you to save images and video clips to internal memory, as well as exporting to USB.
Nigel Perry from BCF said: "This is an excellent entry level system that provides high quality images at a great price - only £6,500 for the system including one probe. The Mindray DP-50's easy to use menu system and superb image makes this scanner such a useful tool for a general veterinary practice."
Angus McPherson from Lomond Hills Veterinary Practice in Fife said: "We were looking for a scanner that was mobile, easy to use and most importantly gave a good image. The scanner was delivered at 9.00am and by 9.30am we had used it on two dog cases. One with a pyometra and one with an enlarged abdomen."
The DP-50 is exclusively available through BCF. For more information, call +44 (0)1506 460 023 or visit www.bcftechnology.co.uk.
The Royal College of Veterinary Surgeons Charitable Trust has announced 'Open Educational Resources to help new practitioners cope', a new initiative that will focus on the needs of veterinary graduates starting out in practice
The project will be jointly funded by the Higher Education Academy and JISC, who have agreed to provide a maximum of £25,000.
The project will identify the key needs of today's new veterinary graduates, and review what available ('open educational') resources already exist or can be adapted to meet those needs. The project will also encourage the sharing of these resources, and other ways of making these more accessible to new veterinary surgeons.
Nick Short, RCVS Trust trustee and Head of eMedia Unit at the Royal Veterinary College said: "New graduates moving from university to veterinary practices can face significant challenges, whether these come from long hours, demanding clients or finding that limited supervision may be offered by their employers. Veterinary practice by its nature can be emotionally fraught as well as intensely rewarding, as it involves, for example, helping clients make decisions about the treatment or euthanasia of pets, or advising farmers about valuable livestock. This means it's important that appropriate support is available to new practitioners."
The Trust will work in partnership with UK veterinary schools and other organisations on this project, and will aim to complement the Royal College of Veterinary Surgeons' Professional Development Phase (PDP) for new graduates, and in particular the set of 'Year One Competences' that new graduates are expected to achieve within approximately their first year in practice. Supervision during the PDP is provided by the vet's employer and progress towards achieving the Year One Competences is monitored by their RCVS-appointed Postgraduate Dean, so the Trust's project will look at what other resources are available or could be adapted to support new graduates as they attain this level of competence.
A project co-ordinator is being recruited to work until September on the project, after which the findings will be disseminated through a report and associated workshop. Further details about the project and the project co-ordinator role can be found at www.rcvstrust.org.uk/graduateoer
The British Veterinary Association has announced that it has almost halved the cost of attending its annual Congress this September.
According to the BVA, the decision was made to demonstrate its commitment to providing high-quality, affordable CPD.
The two-day event will now cost £150 +VAT for members and £300 +VAT for non-members for up to 11 hours of small animal CPD provided by the University of Liverpool.
The choice of topics includes:
The BVA says all the lectures will be delivered by leading experts in their field.
Alongside the clinical CPD programme BVA will run its contentious issues stream with discussions around the impact of women on the profession, horses for sport and the use of antimicrobials.
BVA Past President and small animal vet Harvey Locke worked with the University of Liverpool to create the clinical CPD programme. He said: "With a small animal clinical programme provided by the University of Liverpool, the BVA this year not only provides world-class CPD at Congress but it also comes at a fantastic price.
"BVA is committed to providing high-quality CPD to our members at affordable rates. We look forward to welcoming vets to Liverpool in September for our great value CPD programme."
BVA Congress takes place in Liverpool on 27-29 September at the Merseyside Maritime Museum.
The full programme and further information is available at www.bva.co.uk/congress.
Captains Nicola Housby-Skeggs and Claire Budge, the first two members of the Royal Army Veterinary Corps (RAVC) to achieve the RCVS Certificate in Advanced Veterinary Practice (CertAVP), have been presented with their certificates at Belgravia House.
The two Captains were visiting the RCVS as part of a 'Meet the RCVS Day' organised for a group of Officers from the RAVC. The Captains were presented with their Certificates by Vice-President Peter Jinman.
Capt Nicola Housby-Skeggs had completed a mixture of small animal and equine modules in order to achieve her Certificate, and was positive about the modular approach. She said: "It's reassuring to know you can have a break if you need to. The compulsory module on professional key skills was also more useful than I had anticipated, as it focused on aspects that you don't really have time for at vet school, such as management, and health and safety."
Meanwhile, Captain Claire Budge appreciated the fact that many of her modules could be completed via distance learning. She said: "It was great that I could continue with my studies even when serving in Afghanistan. My only regret is that when I started the Certificate back in 2008, there wasn't the range of modules available that there is now. For example, I would like to have done one of the new Animal Welfare, Ethics and Law modules. However, there is no reason why I can't just take this as continuing professional development - that's the benefit of the modular approach."
More information about the CertAVP can be found at www.rcvs.org.uk/modcerts.
'Meet the RCVS Days' give members of the veterinary team the opportunity to visit the College and find out what goes on behind the scenes. If you would like to join a future event, please let Fiona Harcourt know, on f.harcourt@rcvs.org.uk. Reasonable travel expenses are paid.
Norbrook Laboratories has launched a long-acting cattle bolus which it says will reduce the risk of Milk Fever.
According to the company, Calcitrace D3 is the first and only long-acting bolus to offer slow and fast releasing calcium to provide sustained calcium levels for 48 to 72 hours. In addition, Calcitrace D3 provides Magnesium, Phosphate and Vitamin D3 making it the most comprehensive bolus available.
Calcitrace D3 is smooth gelatin coated bolus with a rounded tip designed for easier administration. Norbrook says it is smaller than other boluses making it less likely to cause trauma on the orpharynx during administration.
Dr Barry McInerney, Norbrook's GB Veterinary Advisor said: "Milk Fever is a common metabolic disorder in dairy cattle which generally affects older, high producing cows and is caused by a rapid decrease in calcium concentrations in the blood just before calving. It is estimated that 3-10% of cows are affected by Milk Fever with a cost of more than £200 per incident so it is crucial that farmers and vets reduce the risk as effectively as possible.
"Norbrook's new Calcitrace D3 bolus which should be administered just before calving, provides higher calcium blood levels during the critical 12 - 48 hour post calving period and provides sustained increased levels for well beyond 48 hours. With the addition of Magnesium, Phosphate and Vitamin D3, Calcitrace D3 provides additional protection against Milk Fever."
Andrew Hillan MVB MRCVS, Director of Veterinary Sciences at Norbrook, led the development of Calcitrace D3. He said: "The launch of Calcitrace D3 is another illustration of the very high quality of technical expertise that exists within our research and development department and underlines Norbrook's commitment to developing high quality and innovative products. It comes from a strong and exciting pipeline of new products which we will bring to the market over the next couple of years."
The RCVS Charitable Trust is seeking two creative and energetic UK-based veterinary students to attend the British Science Festival in Aberdeen from 4-9 September 2012.
The Trust says that the students will be required to use their observations and experiences to help it develop future outreach activities to inform and inspire public audiences about aspects of veterinary clinical practice and research, and will have all their expenses paid by the Trust.
Entrants need to write to the RCVS Charitable Trust to say how they would go about meeting this challenge, ideally giving examples that demonstrate their proven innovative abilities. The deadline for entries is 9 July, after which the entries will be considered by a competition panel who will decide the winners. Entrants must be able to commit to attending the entire festival and to deliver a feedback presentation to the competition panel on 31 October. Entrants should also be willing and able to compile a video diary or blog to feedback their experiences.
Further information and details about how to enter are available at http://trust.rcvs.org.uk/home/. The successful applicants will be announced at the end of July.
ProteqFlu, the live attenuated canarypox equine influenza (EI) vaccine, has had its shelf life extended from 27 to 36 months.
Merial says the increased shelf life is the result of ongoing investment in vaccine research & development, and that the new data underpins the stability of modified live vaccine technology.
Merial highlights that ProteqFlu is the only equine flu vaccine in Europe to include the updated American clade 1 Ohio/03 strain in accordance with the OIE recommendations (2004).